After undershooting analyst sales forecasts in the first quarter, Eli Lilly’s psoriasis drug Taltz is on the hot seat in an immunology market packed with blockbusters. Lilly is hoping some new data on ...

Eli Lilly's Taltz and Novartis' Cosentyx have been jockeying for IL-17 inhibitor supremacy with back-and-forth FDA approvals for years. But in the race for a fourth indication, Taltz has come out on ...

Two decades ago, Eli Lilly and Co. boasted just one blockbuster drug: the groundbreaking antidepressant Prozac, which produced $2.8 billion in revenue at its peak in 1998. Over the next few years, the ...

Eli Lilly and Co. has won federal approval to market its hot-selling anti-inflammatory drug Taltz for another use: treatment of a type of arthritis that does not show any structural body damage on ...

Medicare may cover Taltz (ixekizumab) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Taltz is a brand-name biologic drug that doctors ...

INDIANAPOLIS, March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application ...

INDIANAPOLIS, June 16, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the majority of patients with active psoriatic arthritis (PsA) treated with Taltz ® (ixekizumab) ...

(Reuters) - Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a ...

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Taltz demonstrated high levels of ...